内容摘要：It wasn’t until last week — after the number of cases grew to more than 700, and a second young child in Texas had died from a measles infection — that the Centers for Disease Control and Prevention finally issued its correspondence.

It wasn’t until last week — after the number of cases grew to more than 700, and a second young child in Texas had died from a measles infection — that the Centers for Disease Control and Prevention finally issued its correspondence.

Food and Drug Administration (FDA) commissioner Marty Makary speaks during a news conference on the FDA’s intent to phase out the use of petroleum-based synthetic dyes in the nation’s food supply at the Hubert Humphrey Building Auditorium in Washington, Tuesday, April 22, 2025. (AP Photo/Jose Luis Magana)The administration’s promise of a new vaccine framework comes ahead of a Thursday meeting where FDA advisers will discuss updating COVID-19 shots for this fall and winter.

The FDA’s credibility has long rested on the independence of its scientific decisions. While the agency is led by a handful of political appointees, approval decisions are almost always handled by career scientists.But that standard appears to be shifting. FDA staffers were poised to approveearly last month but the decision was delayed by administration officials, including Makary, according to two people with direct knowledge of the situation who spoke on condition of anonymity to discuss agency matters. The shot was approved late Friday with unusual restrictions.

Dr. Tracy Beth Hoeg — a political appointee serving as Makary’s special assistant — was involved in the unprecedented demand that Novavax conduct a new clinical trial of its shot after approval, according to the people. The requirement came shortly after the agency’s longtime vaccine chief,, was forced to resign.

Hoeg — along with Makary and Prasad — spent much of the COVID-19 pandemic criticizing the FDA’s handling of booster shots, particularly in children and young adults. All three were co-authors of a 2022 paper stating that requiring booster shots in young people would cause more harm than benefit.

Novavax isn’t the only vaccine manufacturer already affected by changing attitudes at FDA. Earlier this month, Moderna pushed back the target date for its new COVID-and-flu combination vaccine to next year after the FDA requested additional effectiveness data.It’s best to avoid placing cacti and succulents, fruiting plants and any that are native to deserts or have low water needs in a humid environment.

In general, seek out tropical plants with sunlight requirements that match your bathroom’s conditions.Adding even one plant to your bath or powder room will

and provide the spa-like vibe you deserve.Jessica Damiano writes regular gardening columns for the AP and publishes the award-winning